Author information
1Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA and Tulane University School of Medicine, New Orleans, LA.
Abstract
BACKGROUND:
Hepatitis C screening is now recommended for all individuals born between the years 1945-1965 in addition to individuals who have high-risk factors. Although most clinicians have extensive experience with the diagnosis and treatment of the disease, they have limited experience screening for it.
METHODS:
We report current screening guidelines and methods.
RESULTS:
By identifying the disease as early as possible, screening and treatment can reduce morbidity and mortality.
CONCLUSION:
Screening for hepatitis C leads to the appropriate evaluation and treatment of individuals chronically infected with the hepatitis C virus and prevents the progression of liver disease to cirrhosis, hepatocellular carcinoma, and the associated morbidity and mortality. Screening for hepatitis C is also cost effective.